Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto M Risi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Organic Letters|February 7, 2012
Synthesis of (+)-patulolide C via an asymmetric hydroformylation/macrocyclization cascadeRoberto M Risi, Steven D Burke
Organic Letters|May 8, 2012
Synthesis of the Prelog-Djerassi lactone via an asymmetric hydroformylation/crotylation tandem sequenceRoberto M Risi, Steven D Burke
The Journal of Organic Chemistry|November 15, 2014
Asymmetric hydroformylation-initiated tandem sequences for syntheses of (+)-patulolide C, (-)-pyrenophorol, (+)-decarestrictine L, and (+)-prelog djerassi lactoneRoberto M Risi, Andrew M Maza, Steven D Burke
The Journal of Organic Chemistry|November 1, 2023
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467Patrick B Brady, Bryan K Sorensen, Roberto M Risi, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Nature|May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Organic Letters|February 7, 2012
Synthesis of (+)-patulolide C via an asymmetric hydroformylation/macrocyclization cascadeRoberto M Risi, Steven D Burke
Organic Letters|May 8, 2012
Synthesis of the Prelog-Djerassi lactone via an asymmetric hydroformylation/crotylation tandem sequenceRoberto M Risi, Steven D Burke
The Journal of Organic Chemistry|November 15, 2014
Asymmetric hydroformylation-initiated tandem sequences for syntheses of (+)-patulolide C, (-)-pyrenophorol, (+)-decarestrictine L, and (+)-prelog djerassi lactoneRoberto M Risi, Andrew M Maza, Steven D Burke
The Journal of Organic Chemistry|November 1, 2023
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467Patrick B Brady, Bryan K Sorensen, Roberto M Risi, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Nature|May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Pageof 1